1. News
  2. Sector

  3. Pharma & Healthcare

Wipro transforms Customer experience at SRL Diagnostics with Oracle Service Cloud

India Infoline News Service  | Mumbai October 31, 2014 14:19 IST

Wipro's CRM team aided SRL in streamlining their call center operations by leveraging the core benefits of the Oracle Service Cloud and providing an incident tracking mechanism.

Bliss GVS Pharma falls on poor earnings

India Infoline News Service  | Mumbai October 31, 2014 12:37 IST

The stock has now slipped over 3.5 per cent on the BSE.

Divi's Labs at 52-week high ahead of results

India Infoline News Service  | Mumbai October 31, 2014 12:28 IST

The stock has gained 2 per cent in early noon deals on the BSE.

Pharmaceuticals Newsletter - October 27 to 31, 2014

India Infoline News Service  | Mumbai October 31, 2014 11:32 IST

Glenmark Pharmaceuticals Ltd posted a net profit/(loss) after taxes, minority interest and share in profit/(loss) of associates of Rs. 1650.78 mn for the quarter ended September 30, 2014 as compared to Rs. 1542.97 mn for the quarter ended September 30, 2013.

Glenmark Pharma Q2 net profit at Rs1650.78 mn

India Infoline News Service  | Mumbai October 30, 2014 16:48 IST

Total Income has increased from Rs. 14767.84 mn for the quarter ended September 30, 2013 to Rs. 16816.78 million for the quarter ended September 30, 2014.

ICRISAT scientist receives Japan's Niigata International Food Award

India Infoline News Service  | Mumbai October 30, 2014 16:35 IST

The prestigious award is in recognition of Dr Gowda's contributions of Asia and sub-Saharan Africa in his nearly 40 years of scientific research work at ICRISAT.

Scottish & Indian Universities partner for Research and Innovation

India Infoline News Service  | Mumbai October 30, 2014 16:18 IST

Drug Discovery Centre will focus on effective prevention and treatment of the ever-increasing range of infections and in major diseases.

Nita M Ambani invited to join the global war against Cancer

India Infoline News Service  | Mumbai October 30, 2014 16:03 IST

Sir H.N. Reliance Foundation Hospital and Research Centre, which was rededicated to the city of Mumbai last week by the Hon'ble Prime Minister Narendra Modi, has Oncology as a thrust area.

Ajanta Pharma surges 5% on solid Q2

India Infoline News Service  | Mumbai October 30, 2014 15:07 IST

The company reported 41 per cent jump in Q2 net profit.

Ajanta Pharma Q2 net profit at Rs786.30 mn

India Infoline News Service  | Mumbai October 30, 2014 14:49 IST

Total Income has increased from Rs. 2861.30 mn for the quarter ended September 30, 2013 to Rs. 3532.00 million for the quarter ended September 30, 2014.

Neuland Laboratories Q2 revenue up 18%

India Infoline News Service  | Mumbai October 30, 2014 14:36 IST

Neuland reported EBITDA of $2.87 million (Rs177.1 mn) in the second quarter of FY 2015, compared to EBITDA of $2.33 mn (146.9 million INR)in the comparable period in FY 2014, anincrease of 21%.

Clariant achieves 8% sales growth

India Infoline News Service  | Mumbai October 30, 2014 11:14 IST

Clariant achieved double-digit local currency sales growth in the emerging markets, led by Latin America with a 23% sales

Lupin's results margins reflect base business strength: IIFL Institutional Report

India Infoline News Service  | Mumbai October 30, 2014 09:11 IST

Strong growth prospects in other territories and an improved margin profile make Lupin one of our best picks in large-cap pharma space

Laurus Labs announces INR 550 cr Investment by Warburg Pincus

India Infoline News Service  | Mumbai October 29, 2014 15:56 IST

The company has grown rapidly since its first full year of commercial operations in 2008, recording revenues of around INR 1,200 crores in FY2013-14.

Dr Reddys Laboratories stock down 2% on Q2 results

India Infoline News Service  | Mumbai October 29, 2014 12:38 IST

The stock has hit a high of Rs3117 and a low of Rs2996.

Novartis net sales up 4% in Q3

India Infoline News Service  | Mumbai October 29, 2014 12:35 IST

Growth products grew 21% (USD) to US$4.9bn or 33% of Group net sales in Q3

Dr Reddy's Laboratories Q2 PAT at Rs574 crores

India Infoline News Service  | Mumbai October 29, 2014 12:23 IST

Total Income has increased from Rs. 34211.20 mn for the quarter ended September 30, 2013 to Rs. 36143.70 million for the quarter ended September 30, 2014.

Jubilant Life slumps 10% as loss widens

India Infoline News Service  | Mumbai October 29, 2014 09:54 IST

The stock so far has plunged to a low of Rs 144.

Dr. Reddy's Laboratories launches Sirolimus Tablets 1 mg and 2 mg

India Infoline News Service  | Mumbai October 29, 2014 08:22 IST

The RAPAMUNE tablets brand had U.S. sales of approximately $206 Million MAT for the most recent twelve months ending in August 2014 according to IMS Health*.

Back to Top

 

 
 
 
Recent Reports
News